Heart Disease Clinical Trials in Baltimore

Showing 501-505 of 505 trials

Predictor of Advanced Subclinical Atherosclerosis

NCT00245284

Evaluation of skin cholesterol for cardiovascular risk assessment in asymptomatic individuals at low, intermediate, or high risk based on Framingham Global Risk estimates. Carotid intima-media thickness (IMT), a surrogate marker for atherosclerotic burden, that independently predicts the occurrence of heart attack and stroke, will be the "gold standard" comparator. Hypothesis: Skin cholesterol, as measured by two non-invasive tests, correlates with CAD, as measured by CIMT in this population.

Coronary Artery Disease

PreMD600 participantsStarted Sep 2005

Chicago, Illinois, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +3 more locations

COMPLETEDPhase 3< 1 mile

Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures

NCT00042081

The purpose of this study is to determine the efficacy of graft pretreatment with CGT003 (E2F Duplex Decoy), as compared to placebo, on the incidence of patients experiencing vein graft failure after coronary artery bypass surgery.

Coronary Artery Disease

Anesiva, Inc.3,000 participantsStarted Jul 2002

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +151 more locations

Predictor of Advanced Subclinical Atherosclerosis

Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures

Heart Disease Trials in Other Cities

The STRETCH Study: Distensibility on Endothelial-Dependent Vasoreactivity in Subjects With Systolic Hypertension

African-American Heart Failure Trial

Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection

Other Conditions in Baltimore